Mainz Biomed B.V. (MYNZ)

USD 3.37

(1.2%)

Gross Profit Summary of Mainz Biomed B.V.

  • Mainz Biomed B.V.'s latest annual gross profit in 2023 was 509.65 Thousand USD , up 179.8% from previous year.
  • Mainz Biomed B.V.'s latest quarterly gross profit in 2023 FY was 509.65 Thousand USD , up 179.8% from previous quarter.
  • Mainz Biomed B.V. reported a annual gross profit of 182.15 Thousand USD in annual gross profit 2022, up 2.55% from previous year.
  • Mainz Biomed B.V. reported a annual gross profit of 177.62 Thousand USD in annual gross profit 2021, up 44.31% from previous year.
  • Mainz Biomed B.V. reported a quarterly gross profit of 138.94 Thousand USD for 2023 Q1, up 282.8% from previous quarter.
  • Mainz Biomed B.V. reported a quarterly gross profit of 509.65 Thousand USD for 2023 FY, up 179.8% from previous quarter.

Annual Gross Profit Chart of Mainz Biomed B.V. (2023 - 2019)

Historical Annual Gross Profit of Mainz Biomed B.V. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 509.65 Thousand USD 179.8%
2022 182.15 Thousand USD 2.55%
2021 177.62 Thousand USD 44.31%
2020 123.08 Thousand USD 300.89%
2019 -61.27 Thousand USD 0.0%

Peer Gross Profit Comparison of Mainz Biomed B.V.

Name Gross Profit Gross Profit Difference
Aspira Women's Health Inc. 5.26 Million USD 90.314%
bioAffinity Technologies, Inc. 791.61 Thousand USD 35.618%
Intelligent Bio Solutions Inc. 1.42 Million USD 64.25%
Standard BioTools Inc. 50.45 Million USD 98.99%
Inotiv, Inc. 165.44 Million USD 99.692%
Prenetics Global Limited 8.82 Million USD 94.228%
Neuronetics, Inc. 51.7 Million USD 99.014%
Star Equity Holdings, Inc. 11.92 Million USD 95.726%
Castle Biosciences, Inc. 174.8 Million USD 99.708%
Psychemedics Corporation 8.41 Million USD 93.942%
RadNet, Inc. 93 Million USD 99.452%
Exact Sciences Corporation 1.84 Billion USD 99.972%
IDEXX Laboratories, Inc. 2.18 Billion USD 99.977%
iSpecimen Inc. 5.1 Million USD 90.022%
OpGen, Inc. -90.69 Thousand USD 661.954%
Exagen Inc. 29.45 Million USD 98.27%
Bionano Genomics, Inc. 9.56 Million USD 94.672%
CareDx, Inc 178.32 Million USD 99.714%
Check-Cap Ltd. -212 Thousand USD 340.405%
Twist Bioscience Corporation 133.34 Million USD 99.618%
Guardant Health, Inc. 336.89 Million USD 99.849%
Biodesix, Inc. 36.07 Million USD 98.587%
BioNexus Gene Lab Corp. 1.32 Million USD 61.665%
Precipio, Inc. 6.01 Million USD 91.531%
Natera, Inc. 492.74 Million USD 99.897%
Fulgent Genetics, Inc. 104.45 Million USD 99.512%
Sera Prognostics, Inc. 96 Thousand USD -430.895%
23andMe Holding Co. 99.37 Million USD 99.487%
OPKO Health, Inc. 318.12 Million USD 99.84%
Personalis, Inc. 18.2 Million USD 97.201%
Aclaris Therapeutics, Inc. 13.16 Million USD 96.13%
Applied DNA Sciences, Inc. 5.53 Million USD 90.789%
T2 Biosystems, Inc. -8.17 Million USD 106.238%
Neogen Corporation 463.9 Million USD 99.89%
Myriad Genetics, Inc. 476.4 Million USD 99.893%
ICON Public Limited Company 1.81 Billion USD 99.972%
NeoGenomics, Inc. 244.6 Million USD 99.792%
Star Equity Holdings, Inc. 11.92 Million USD 95.726%
MDxHealth SA 43.92 Million USD 98.84%
Prenetics Global Limited 8.82 Million USD 94.228%
Illumina, Inc. 2.74 Billion USD 99.981%
DarioHealth Corp. 5.98 Million USD 91.483%
ENDRA Life Sciences Inc. -275.45 Thousand USD 285.027%
Medpace Holdings, Inc. 524.5 Million USD 99.903%
Trinity Biotech plc 19.45 Million USD 97.38%
Sotera Health Company 577.15 Million USD 99.912%
bioAffinity Technologies, Inc. 791.61 Thousand USD 35.618%